Showing posts with label Psychobiotics Market. Show all posts
Showing posts with label Psychobiotics Market. Show all posts

Friday, 10 September 2021

Mental Health Awareness in Post-pandemic Era | TechSci Research

It's been over a year since the COVID-19 pandemic struck the world with full force, and the battle is still ongoing with new fast-spreading variants and renewed lockdown measures. The devastation of the pandemic causing millions of deaths, economic strife, financial burden, and social constraints marked a significant effect on the mental health of people across the world. Lingering fear and uncertainty about the coronavirus itself, housing and food insecurity, job losses, social isolation, and post-traumatic stress are contributing to a rise in anxiety, insomnia, and depression amid the pandemic. As per a recent study, mental health issues account for 13% of the world’s disease burden.

As per the latest report by the USA Centers for Disease Control & Prevention (CDC), the number of people with symptoms of anxiety or depressive disorder increased from 36.4-41.5% between August 2020 and February 2021, majorly due to the COVID-19 pandemic. As the weight of the crisis is gradually lifting, many health experts are expecting long-term implications of the pandemic on mental health in the coming years, which could put an even greater strain on the already stressed mental health system.

Alcohol abuse, anxiety, anger, depression, and post-traumatic stress symptoms became common problems during the quarantine period due to prolonged social distancing measures. The mental health issues further aggravated with an economic and social crisis during the pandemic. Besides, having inadequate basic supplies of food, mask, clothes, water, or accommodation for a large group of the population during quarantine led to frustration. The social distancing has been particularly challenging for children and teens who were confined within their houses, feeling a sense of void and restlessness. Besides, an increase in screen time, less physical activities, and poor dietary patterns led to worse behavioral and emotional responses.

Patients with mild to severe COVID-19 symptoms suffered from psychological effects post recovering from the infection. Many of those recovered from COVID-19 reported experiencing “Covid fog”, post-traumatic stress, anxiety, sadness, exhaustion, and depression. The long-term physical health implications such as muscle aches, weakness, breathlessness, etc. impacted mental health more severely, adding a sense of fear and aggravating uncertainty.

Psychological Impact of Frontline Healthcare Professionals 

The frontline workers had to face the wrath of COVID-19 not only on a physical and emotional level but also on a psychological level. Healthcare workers around the globe were exposed to an extreme and unprecedented spike in infection cases, which completely disrupted their work-life balance. While experiencing threats to their own safety, they were treating other people with high COVID-19 infection wearing the PPE kits for long exhaustive hours, which was physically and mentally draining. Some health authorities had to stay away from their families to avoid the risk of contamination, which added to their mental distress. The shocking death rates were traumatizing for the healthcare professionals operating in a crowded care setting. Besides, the limited resources at the healthcare facilities in highly demanding situations put a burden on the hospital staff. 

The intense workload, sleep deprivation, high rates of cynicism among mentors and colleagues, fears over inadequate personal protection, lack of control, isolation from families, and potentially low social support traumatized many health care workers and exacerbated their existing anxiety. According to a survey conducted by Mental Health America (MHA), almost 93% of the healthcare workers reported experiencing stress, 86% reported anxiety, 77% reported frustration, 76% reported exhaustion and burnout.

Mental Burden of Job Losses 

The wide-scale suspension of economic activities resulting from the COVID-19 pandemic led to job losses, which impaired mental well-being significantly. The increasing health costs had put immense pressure on workers whose wages were low or were forced into temporary positions. As the pandemic intensified, employer-employee bond broke and temporary layoffs increased, which amplified societal and economic damages. Besides, the overall economic contraction resulted in steep competition for work, which has aggravated stress on the unemployed population seeking a job. In the USA, the unemployment rate rose from 3.8% in 2019 to 8.6% in 2020 while in European Union, the rate grew from 6.9% to 7.1%. The job not only impacts financial stability, but also work-life balance, daily structures, and an essential sense of self-purpose, which often leads to reduced self-esteem. Besides, the insecurity of income and the risk of a drop in standard of living in future adds to the anxiety arising from joblessness.

Remote Working During COVID-19

The sudden shift to remote working has been stressful for many employees with the sudden lack of physical connection, resulting in isolation and burnout. Without the necessary support, employees tend to feel more stressed and anxious. Even the work becomes more challenging with the no disconnect between home and office life. Besides, the new trend of the virtual meeting provides fewer opportunities for informal catchups, which triggers fatigue and leaves participants feeling-ironically-disconnected. The heightening psychological and emotional workload amounts to intensified stress and anxiety levels, which could be bad for long-term employee well-being. With absolutely no physical mobility and less exercise, employees are developing musculoskeletal problems and disturbed sleep, impacting their mental health even more.

After months of non-stop video calling, the monotony of sitting for long hours led to an issue of “virtual meeting burnout”, which resembles a feeling of fatigue, exhaustion, or drain. The constant self-evaluation in front of the camera increases cognitive workload and reduces the level of concentration for the task on hand, resulting in overall less productivity.

Increase in Online Psychotherapy

With the rising cases of mental disorders across the globe, online counseling searches increased by 124%. The popularity of online counseling in the form of instant messaging, emails, and video chats spiked in demand as people were unable to access face-to-face counseling. People who experienced uneasiness and social separation are likely to make deep and meaningful conversations with online/cyber counselors than with in-person counselors. Online counseling overcomes the logistical limitations of traveling great distances to have a therapy session. People with a physical condition can also gain access to teletherapy without having to worry about adequate transportation. Besides, patients cannot miss their therapy sessions due to traffic, bad rains, or illnesses, allowing more consistent care, which increases the chances of mental health improvement. As per a recent study, people who undergo message-based online therapy are likely to experience a 50% reduction in depressive symptoms and a 57% decrease in anxiety symptoms with 4 months of consistent counseling and care. The cost-effectiveness of online therapy makes it a viable alternative for people unable to seek comparatively expensive traditional counseling. 

Reducing Stigma Around Mental Health 

There has been a significant decrease in stigma and negative assumptions related to mental illnesses. More and more people are now openly talking about their mental health disorders, which is helping to reduce the stigma associated with them. Even celebrities are publicly sharing their mental health struggles and backing initiatives to tackle mental health. Funding in medical health start-ups has also tripled over the past five years, and sales of mental health-related books have amplified. However, people eager to seek mental health treatments tend to face some challenges such as health plans not covering mental health conditions on a part with medical issues, shortage of qualified professionals, inadequate quality of mental health treatment, etc. As per the World Health Organization, COVID-19 disrupted mental health services in 93% of countries while countries spend less than 2% on mental health budgets. According to recent data, 75% of Americans and Europeans do not seek mental health treatment due to fear of anxiety, embarrassment, shame, or societal pressure. Educational campaigns can help to normalize conversations surrounding mental health even further.

According to TechSci Research report, “Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others) By Region, Competition Forecast & Opportunities, 2026”, global psychobiotics market is anticipated to grow at a formidable CAGR owing to the rising demand for probiotics for the psychological ailments and rising instances of mental health disorders across the world. The coronavirus pandemic has further exacerbated the mental health ailments, leading to the growth in demand for global psychobiotics, which is accelerating its market growth.

Monday, 9 August 2021

Psychobiotics Market to Grow with an Impressive CAGR During the Forecast Period | TechSci Research

Advancing healthcare industry is driving the growth in Global Psychobiotics Market in the forecast period, 2022-2026.

Psychobiotics Market - TechSci Research
According to TechSci Research report, Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others) By Region, Competition Forecast & Opportunities, 2026, the global psychobiotics market may potentially project an impressive growth in the forecast period, 2022-2026, with an impressive CAGR on the account of rising number of depression and anxiety cases among the population.

The young population is more inclined toward self-diagnosing and self-medication, and along with the health concerns among the population, the market is anticipated to show robust growth in the future five years. Moreover, easier availability of the psychobiotics in the form of food supplements, nutritional supplements, and special nutrients; the market is bound to experience the anticipated growth in the CAGR in upcoming five years.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Psychobiotics Market"

https://www.techsciresearch.com/report/psychobiotics-market/7678.html

The global psychobiotics market is segmented by type, psychotropic agent, form, distribution channel, application, competitional landscape, and regional distribution. Based on psychotropic agent, the market is further bifurcated into Streptococcus, Lactobacillus, Clostridium, and others. Streptococcus is a genus of bacteria that is gram-positive and belongs to the family of Straptococcaceae. The bacteria are taken in its inactive form and through biotechnological procedures is abetted for the procedure of manufacturing psychobiotics. Bifidobacterium is also a gram-positive anaerobic bacterium that is inhabitant to human gastrointestinal tract. The bacteria are affective in psychological anxiety and stress ailments along with its widely pronounced functions in digestion.

Based on type, the market is further segmented into food supplements, nutritional supplements, specialty nutrients, and infant formula. Nutritional supplements are anticipated to hold the largest revenue shares of the market and assert its dominance over the market on the account of rapidly growing number of consumers inclined toward self-medication. The consumers are eagerly adapting the psychobiotics as a nutritional supplement for healthy brain. Large population is suffering from depression, stress and anxiety. The tendency of self-diagnosing and self-medication is very active among the young population and thus they are aiding to the growth of the global psychobiotics market in the upcoming five years forecast, until 2026.

Holding the major shares of the global psychobiotics market are Innovix Labs, Bened Biomedical Co., Ltd, Nutrimmun GmbH, Kerry Group Plc., Sabinsa Corporation, Lallemand Health Solutions Inc., DuPont de Nemours, Inc., Uplift Food Pty Ltd., Nature's Bounty Co. Ltd., BioGaia Group, The Life Extension Foundation, Lifted Naturals, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through psychobiotics. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7678

Customers can also request for 10% free customization on this report.

“North America is anticipated to be the most volatile and most promising market in the future five years. The region consists of the United States and Canada likewise major economies that support excellent healthcare within the country and the presence of multiple market players that hold major shares of the market are other major factors that is expected to support the growth of the market too. Moreover, the consumers of the United States are accounting to maximum number of consumers along with the rapidly growing health-conscious consumers. Asia Pacific may also register itself as a self-reliant market in the next five years on the account of rapidly evolving healthcare industry in the region as well as rapidly increasing cases of depression and anxiety,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

Global Psychobiotics Market By Type (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula) By Psychotropic Agent (Streptococcus, Bifidobacterium, Lactobacillus, Clostridium, Others) By Form (Powder, Liquid/Fluid, Tablets) By Distribution Channel (Retail Shops, Hypermarkets/Supermarkets, Drug Store/Pharmacy, Online) By Application (Gastrointestinal Function, Antidepressant, Anxiolytic, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, Schizophrenia, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global psychobiotics and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global psychobiotics market.

Browse Related Reports:

Global Nasal Drug Delivery Market By Drug Type (Antihistamines, Corticosteroids, Anesthetics, Antibiotics, Pain Relief Drugs, Others), By Dosage Form (Sprays, Drops, Powder, Gels & Ointments), By Container Type (Non-pressurized Containers, Pressurized Containers), By Basis of System (Metered Dose, Multi-Dose, Unit Dose), By Therapeutic Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion), By End User (Home Care Settings, Hospitals, Clinics), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/nasal-drug-delivery-market/5174.html

Global Anti-Viral Drugs Market By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, m-RNA Synthesis Inhibitors, Integrase Inhibitors, Others) By Indication (Coronavirus Infection, HIV, Hepatitis, Herpes Simplex Virus, Influenza, Others (Pneumonia, Flu)) By Route of Administration (Oral, Topical, Parenteral, Others) By Type (Branded, Generic) By Age Group (Pediatric, Adult, Geriatric) By End-User (Hospitals, Homecare, Specialty Clinics, Others) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) By Region, Competition Forecast & Opportunities, 2026

https://www.techsciresearch.com/report/anti-viral-drugs-market/7550.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/